On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
SHL is set on presenting its strong pipeline of autoinjectors designed for high volume and high viscosity drug formulations.
SHL Group announced plans to create 800 new jobs in Taiwan to support ramped up productions for SHL Medical.
Capitalizing on Taiwan’s advanced position in electronics and software development, the company also aims to set up an incubator to establish its footprint in the digital healthcare industry.
SHL Technologies is the proud recipient of the Outstanding Supplier Award from its key customer ASM Assembly Systems
The new global CEO for SHL Medical Holding will be Ulrich Faessler. Ulrich has been with SHL for over seven years and has been the Asian Managing Director for SHL Medical for the past five years.
SHL Group and fast-rising healthcare startup QuiO are pleased to announce a strategic partnership on digital technologies that will take the drug delivery industry into connected therapeutics.
With the rapid growth of SHL Group and along with new innovations and technologies developed for pen and autoinjectors, the Taoyuan facility requires expansion of space and thus will be relocating to a new site in Nankan, Taoyuan.
On December 15 and 16, SHL held a donation event for new or second-hand items to be donated to indigenous children of remote areas on the Eastern coast of Taiwan, namely in Taitung and Hualien.